The prognostic impact of age in patients with triple-negative breast cancer

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

(2012) Adam Brufsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling

(2012) Hatem A. Azim et al.   CLINICAL CANCER RESEARCH

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

(2011) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

(2011) Soley Bayraktar et al.   CANCER

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

(2011) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Prognostic Significance of Young Age (

(2011) Eun-Kyu Kim et al.   WORLD JOURNAL OF SURGERY

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

(2010) L. Pusztai et al.   ONCOLOGIST

Triple-negative breast cancer--current status and future directions

(2009) O. Gluz et al.   ANNALS OF ONCOLOGY

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

(2009) Farrah Kassam et al.   Clinical Breast Cancer

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

(2009) Hanna Fredholm et al.   PLoS One

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY